Provided by Tiger Trade Technology Pte. Ltd.

Compass Therapeutics, Inc.

2.40
+0.04001.69%
Pre-market: 2.420.0188+0.78%07:46 EDT
Volume:2.03M
Turnover:4.85M
Market Cap:432.21M
PE:-5.94
High:2.45
Open:2.39
Low:2.33
Close:2.36
52wk High:6.88
52wk Low:1.61
Shares:180.09M
Float Shares:132.00M
Volume Ratio:0.80
T/O Rate:1.54%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4039
EPS(LYR):-0.4216
ROE:-56.66%
ROA:-33.03%
PB:2.60
PE(LYR):-5.69

Loading ...

Compass Therapeutics Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 10

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Aug 07

Analysts Offer Insights on Healthcare Companies: Compass Therapeutics (CMPX) and Halozyme (HALO)

TIPRANKS
·
Aug 07

Relay Therapeutics Q2 Revenue Misses Estimates on Higher R&D Expenses; Net Loss Widens

Reuters
·
Aug 07

Compass Therapeutics Q2 2026 earnings: Pipeline spending widens the net loss

TradingKey
·
Aug 06

CG Oncology Q2 Net Loss Widens on Higher R&D Costs

Reuters
·
Aug 06

Compass Therapeutics Q2 EPS $(0.13) Misses $(0.11) Estimate

Benzinga Earnings
·
Aug 06

Compass Therapeutics Q2 2026 Net Loss Widens 26.63% to $25.2 Million; R&D Expenses Rise 19% to $19.6 Million

Reuters
·
Aug 06

Compass Therapeutics: $180 Mln in Cash and Marketable Securities at End of Q2 2026, Which is Expected to Fund Operations into 2028

THOMSON REUTERS
·
Aug 06

Compass Therapeutics Q2 Income from Operations USD -26.979 Million

THOMSON REUTERS
·
Aug 06

Compass Therapeutics Reports 2026 Second Quarter Financial Results and Provides Corporate Update

GlobeNewswire
·
Aug 06

Compass Therapeutics Announces Tovecimig Data Accepted for an Oral Presentation at the Esmo Congress 2026

THOMSON REUTERS
·
Jul 17

Compass Therapeutics Announces Tovecimig Data Accepted for an Oral Presentation at the ESMO Congress 2026

GlobeNewswire
·
Jul 17

Compass Showcases Promising Tovecimig Data, Eyes Commercialization

TIPRANKS
·
Jul 02

Analysts Offer Insights on Healthcare Companies: Zimmer Biomet Holdings (ZBH), Compass Therapeutics (CMPX) and 10x Genomics (TXG)

TIPRANKS
·
Jul 01

Compass Therapeutics sets Delaware, Massachusetts federal courts as exclusive venue for Securities Act claims

Reuters
·
Jun 23

Compass Therapeutics Shareholders Back Directors, Pay, Auditor Oversight

TIPRANKS
·
Jun 12

Compass Therapeutics shareholders elect Schuetz, Lindahl to board

Reuters
·
Jun 12

Analysts Offer Insights on Healthcare Companies: Praxis Precision Medicines (PRAX), Compass Therapeutics (CMPX) and Tenax Therapeutics (TENX)

TIPRANKS
·
Jun 01

Compass Therapeutics to Participate in Upcoming June Investor Events

GlobeNewswire
·
May 28